Case Reports
doi: 10.1136/bjo.2009.160986.
Macular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular disease
- PMID: 20215378
- DOI: 10.1136/bjo.2009.160986
Item in Clipboard
Case Reports
Macular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular disease
Br J Ophthalmol.
2010 Mar.
No abstract available
Comment on
-
Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.Br J Ophthalmol. 2008 Apr;92(4):518-22. doi: 10.1136/bjo.2007.127282. Epub 2008 Jan 22. Br J Ophthalmol. 2008. PMID: 18211942 Clinical Trial.
-
Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.Br J Ophthalmol. 2009 Apr;93(4):452-6. doi: 10.1136/bjo.2008.141085. Epub 2008 Dec 15. Br J Ophthalmol. 2009. PMID: 19074916 Clinical Trial.
Similar articles
-
Macular infarction following intravitreal bevacizumab for treatment of central retinal vein occlusion.Ophthalmic Surg Lasers Imaging. 2012 Jul 19;43 Online:e73-9. doi: 10.3928/15428877-20120712-05. Ophthalmic Surg Lasers Imaging. 2012. PMID: 22823029
-
Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion.Acta Ophthalmol. 2009 Feb;87(1):77-81. doi: 10.1111/j.1755-3768.2008.01313.x. Epub 2008 Oct 17. Acta Ophthalmol. 2009. PMID: 18937800
-
Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.Retina. 2009 Jun;29(6):757-67. doi: 10.1097/IAE.0b013e31819d4fbf. Retina. 2009. PMID: 19289982
-
The treatment of branch retinal vein occlusion with bevacizumab.Curr Opin Ophthalmol. 2008 May;19(3):234-8. doi: 10.1097/ICU.0b013e3282fb7fb0. Curr Opin Ophthalmol. 2008. PMID: 18408499 Review.
-
Macular ischaemia: a contraindication for anti-VEGF treatment in retinal vascular disease?Br J Ophthalmol. 2012 Feb;96(2):179-84. doi: 10.1136/bjophthalmol-2011-301087. Br J Ophthalmol. 2012. PMID: 22250209 Review.
Cited by
-
Changes in vessel density patterns assessed with OCTA in patients with diabetic macular edema treated with anti-VEGF therapy.Acta Diabetol. 2024 Nov;61(11):1385-1392. doi: 10.1007/s00592-024-02290-5. Epub 2024 May 27. Acta Diabetol. 2024. PMID: 38802603 Free PMC article.
-
Optical coherence tomography angiography microvascular findings in macular edema due to central and branch retinal vein occlusions.Sci Rep. 2017 Jan 18;7:40763. doi: 10.1038/srep40763. Sci Rep. 2017. PMID: 28098203 Free PMC article.
-
Effects of panretinal photocoagulation on retinal vasculature and foveal avascular zone in diabetic retinopathy using optical coherence tomography angiography: A pilot study.J Curr Ophthalmol. 2019 Jul 3;31(3):287-291. doi: 10.1016/j.joco.2019.06.001. eCollection 2019 Sep. J Curr Ophthalmol. 2019. PMID: 31528763 Free PMC article.
-
The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy.Clin Ophthalmol. 2014 Jun 11;8:1119-27. doi: 10.2147/OPTH.S62022. eCollection 2014. Clin Ophthalmol. 2014. PMID: 24959068 Free PMC article.
-
Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients.Clin Ophthalmol. 2013;7:455-60. doi: 10.2147/OPTH.S30156. Epub 2013 Mar 1. Clin Ophthalmol. 2013. PMID: 23467497 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
